Product: Tiglutik (riluzole) Oral Suspension 50 mg/10 mL (5 mg/mL), 600 mL (two bottles/300 mL each), RX only, Manufactured for ITF Pharma, Inc., Berwyn, PA 19312 USA NDC:70726-0303-1 (carton) and 70726-0303-2 (bottle)
Reason for recall: Failed Viscosity Specifications: Out-of-specification test results for viscosity
Recall initiated: 20231020
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated